Discover key insights from e.l.f. Beauty's Q4 2025 earnings call, including the acquisition of rhode, tariff impacts, robust sales growth, and ...

A first-of-its-kind clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobulin ...